Perspectives On Drug Costs: It’s A Drugmaker’s World And We’re All Just Living In It
Editorial and opinion writers offer their takes on drug-cost issues.
Archives: Morning Breakouts
37,021 - 37,040 of 112,624 Results
-
-
How Big Pharma Dodged An Obamacare Overhaul
News outlets report on the pharmaceutical drug industry.
By brilabuskes -
State Highlights: Ariz. Facility’s Staff Contributed To Measles Outbreak, Officials Say; Sweeping Plan To Rein In Health Care Costs In Conn. Unveiled
Outlets report on health news from Arizona, Connecticut, New York, Utah, California, Texas, Colorado and Massachusetts.
By brilabuskes -
Study Of California Suicide Hotlines Finds Room For Improvement
Most of the hotlines studied follow best practices, but researchers point to areas — such as Increasing the availability of chat and text services — where services can be enhanced. In other news, the CDC releases recommendations for the California county that was struck by a pair of suicides clusters.
By brilabuskes -
CDC Partners With WHO To End Violence Against Children
The plan includes a seven-point strategy that consists of measures, such as implementing and enforcing laws that limit young people's access to firearms; changing beliefs and values around gender roles; and creating safe environments by doing things like improving housing.
By brilabuskes -
Proper Pain Management From Parents Can Take Sting Out Of Vaccinations For Kids
More often than not, parents are unaware of the vast amount of children's pain and anxiety management research they can pull from when their kids are getting vaccinated. And doctors aren't providing the information because they say they aren't being asked. In other news, advocates in California want adults to make sure they're getting vaccinated, too.
By brilabuskes -
How A Tough-On-Crime Politician’s Opioid Policy Shifted Toward Treatment Over Punishment
“Once you have the facts, it’s very clear to you," says Frank Guinta, a New Hampshire politician who used to have a single-minded focus of ridding the state of drug dealers. His view has shifted to seeing addiction as an illness rather than a crime.
By brilabuskes -
The Golden Age Of Antibiotics Is Staring Down Its Own Demise
Common ailments are regaining the power to kill as bacteria evolves to resist antibiotics. The Los Angeles Times offers an in-depth look at the issue.
By brilabuskes -
Disability Advocates Press Federal Officials To Get Kansas To Fix Medicaid Backlog
The Disability Rights Center is asking the Obama administration to force Kansas to prove that it is notifying applicants of their right to a hearing if their application isn’t processed within 45 days. Also, another group is staging meetings across the state to rally support for Medicaid expansion.
By brilabuskes -
Theranos’ Downfall Serves As Cautionary Reminder To Silicon Valley Investors
If something seems too good to be true, it just might be. Don't buy into the hype. Pay attention to red flags. These are just some of the lessons investors may take away when they evaluate what happened with the blood-testing startup.
By brilabuskes -
Consumers Can Search Prices For Medical Services With New Online Tool
USA Today spotlights the expanded search from Amino, a data company that launched last year to help patients find doctors. In other health IT news, a new computerized biopsy tool may help pathologists and a Nashville, Tenn., tech company teams up with Uber to transport people to appointments.
By brilabuskes -
With Proper Drugs, HIV-Positive Patients Have Low Risk For Sexual Transmission
A new study finds that patients who are HIV-positive and taking antiretroviral drugs have a low risk of spreading the virus to their partner, even if they are not using condoms. Doctors, however, warn about placing too much weight on the findings. In other news, a look at why the South is so disproportionately hard hit by AIDS.
By brilabuskes -
Merck Plans R&D Layoffs At East Coast Locations
The pharmaceutical company's reorganization also includes new laboratories near Boston and San Francisco with an increased focus on microbiome research.
By brilabuskes -
After 3 Patient Deaths, Juno Therapeutics To Resume Modified Trial Of Anti-Cancer Treatment
The FDA is allowing the continuation after the company said that the deaths of the three young leukemia patients — who developed fatal brain swelling — stemmed not from its treatment but from a chemotherapy drug also used. Juno will drop that chemo drug in the modified trial.
By brilabuskes -
‘Right To Try’ Experimental Medications Stance May Be Adopted In Republican Platform
Laws have passed in 31 states that allow terminal patients access to unapproved treatments. In other development news, a drug to help severe postpartum depression shows promising results in a clinical trial. And, in a first for a major venture capital firm, Flagship Ventures hires a new chief medical officer.
By brilabuskes -
Democrats Will Support Opioid Bill — But They’re Not Happy About It
The package is expected to come up for a vote Wednesday. While Senate Democrats voice concerns about the legislation, they say they will give it their support. The bill authorizes $181 million for drug abuse and treatment programs but does not appropriate the funds.
By brilabuskes -
Zika Battle Rages On As Republicans Dig In With Take-It-Or-Leave-It Stance
On Tuesday, Senate Republicans rejected a new Democratic proposal aimed at finding a middle ground in the battle over Zika funding.
By brilabuskes -
Dems Signal Renewed Interest In Public Option, But Hospitals Want It Out Of Platform
Adding a public option to the insurance market has gained traction of late as both Hillary Clinton and President Barack Obama have voiced support for it. But not everyone thinks it's a good idea.
By brilabuskes -
CMS Counters Attacks That Health Law Insurance Costs Are Too High For Consumers
The agency's report shows that when factoring in financial assistance from the government, the median deductible that consumers actually pay for Obamacare health plans is $850 this year. That's down $50 from the past year. Meanwhile, another co-op is shutting down.
By brilabuskes -
First Edition: July 13, 2016
Today's early morning highlights from the major news organizations.
By brilabuskes